MET vs REPL
MetLife Inc (MET) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
MetLife Inc (MET) is a insurance - life company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
MET does not have a complete income-statement cache yet.
REPL does not have a complete income-statement cache yet.
MET currently screens at market cap $52.16B and trailing P/E 12.7. REPL currently screens at market cap $825.7M.
Not investment advice. Open the MET and REPL stock pages for the full models.
Not investment advice.